“It certainly seems that we're moving into medical management of advanced diseases,” says J. Christopher Webster, MD, FACS.
In this video, J. Christopher Webster, MD, FACS, makes his predictions for future advancements in urology over the next several years. Webster is a urologist with Colorado Urology in Westminster. He was interviewed at the 2022 LUGPA Annual Meeting in Chicago, Illinois.
Long-term follow-up supports pembrolizumab monotherapy in BCG-unresponsive NMIBC
December 2nd 2022Pembrolizumab monotherapy continued to demonstrate durable complete responses, while rates of upstaging at the time of radical cystectomy were consistent with previous findings in the KEYNOTE-057 trial in patients with BCG-unresponsive NMIBC.
2 Clarke Drive
Cranbury, NJ 08512